Jacob Ballas picks 13.1% stake in Vivimed Labs on conversion o...The conversion was at 12 per cent premium to the market price. NYLIM Jacob Ballas Fund III, managed by Jacob Ballas Capital India Pvt Ltd, has acquired 13.1 per cent stake in Hyderabad-based Vivimed Labs Ltd. This follows the conversion of ... VC Circle, 2 months ago |